JV

Jyothi Vyas

Active Director Director DIN 02409541
DIN 02409541 First appointment Mar 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Mar 2005
Shareholding value •••• Premium profile

About Jyothi Vyas

Data last updated:

Jyothi Vyas is a Director at Totus Health Care (India) Limited (since 2014), Additional Director at Paradigm Medivision Private Limited (since 2021) and Designated Partner at Bravespaces Creative India Llp (since 2024). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹25.25 Cr; the largest is Totus Health Care (India) Limited at ₹12.64 Cr (FY 2019). Earlier, Jyothi Vyas was a Director at Avant Garde Medchem Private Limited (2023–2024) and Director at Kyros Therapeutics (India) Limited (2005–2015) and 3 more.

DIN 02409541
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2005
Oldest Company Age 32 yrs
Largest company Totus Health Care (India) Limited · ₹12.64 Cr (FY 2019)
Combined revenue ₹25.25 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Totus Health Care (India) Limited U24239TG1994PLC017578
Director22 May 20141994₹12.64 Cr (FY 2019)Active
Paradigm Medivision Private Limited U24239TG2004PTC043554
Additional Director01 Apr 20212004₹12.61 Cr (FY 2019)Active
Designated Partner22 Jul 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avant Garde Medchem Private Limited U21002TS2023PTC178254
Director19 Oct 20232023₹15,000 (FY 2024)Active
Kyros Therapeutics (India) Limited U24239TG2005PLC045761
Director30 Mar 20052005Active
Director29 Mar 20132012₹20.30 Cr (FY 2019)Under Liquidation
Designated Partner12 Sep 20162016Active
Subi Medicaments Private Limited U24239MP2020PTC053545
Director02 Nov 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jyothi Vyas

Directorship timeline

Open interactive timeline →
Totus Health Care (India) Limited
Paradigm Medivision Private Limited
Subi Medicaments Private Limited
Bravespaces Creative India Llp
Premium access

Shareholding and investment profile for Jyothi Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyothi Vyas

Jyothi Vyas currently holds 3 directorships: Totus Health Care (India) Limited (Director, since 22 May 2014, revenue ₹12.64 Cr (FY 2019)); Paradigm Medivision Private Limited (Additional Director, since 01 Apr 2021, revenue ₹12.61 Cr (FY 2019)); Bravespaces Creative India Llp (Designated Partner, since 22 Jul 2024).

Jyothi Vyas was first appointed on 30 Mar 2005 as Director at Kyros Therapeutics (India) Limited. The most recent appointment on record is 22 Jul 2024 at Bravespaces Creative India Llp.

The 2 current companies of Jyothi Vyas that report revenue have a combined latest revenue of ₹25.25 Cr: Totus Health Care (India) Limited ₹12.64 Cr (FY 2019); Paradigm Medivision Private Limited ₹12.61 Cr (FY 2019).

Jyothi Vyas held 5 earlier board appointments: Avant Garde Medchem Private Limited (Director, 19 Oct 2023 to 24 Feb 2024); Kyros Therapeutics (India) Limited (Director, 30 Mar 2005 to 13 May 2015); Ariston Pharma Nova Tech Private Limited (Director, 29 Mar 2013 to 25 Sep 2019); Paramount Pharmachem Llp (Designated Partner, 12 Sep 2016 to 31 Mar 2019); Subi Medicaments Private Limited (Director, from 02 Nov 2020).

The current boards of Jyothi Vyas's companies include Akhtar Uzzaman (Totus Health Care (India) Limited), Vedprakash Vyas (Totus Health Care (India) Limited), Neha Vyas (Bravespaces Creative India Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available